Dementia blood marker p-tau217 tracks with more than memory in older adults
Alzheimer's and dementiaPart of a story we are following · 14 articles · See every update
If you have heard about new blood tests for Alzheimer’s, here is something worth knowing. A new study found that a blood marker tied to Alzheimer’s goes along with more than memory. It also tracks with how people walk, feel and eat.
In a study of 200 community-dwelling adults aged 60 and older, people with higher blood levels of a dementia-related marker called p-tau217 scored lower on a combined measure of everyday function. That measure covered thinking, movement, mood and nutrition, so the marker seems to reflect your whole day-to-day capacity, not only your memory.
How the study worked
Researchers measured p-tau217 in the blood of 200 older adults living in the community, with an average age of 71.9 years. About 74% were women. They also scored each person on four areas: thinking, physical performance, mood and nutrition. The study, published November 20, 2026 in the J Gerontol A Biol Sci Med Sci, took a single snapshot in time, so it cannot tell which comes first, the marker or the change in function.
What is p-tau217?
p-tau217 is a protein in the blood. Scientists see it as a promising sign of the changes in the brain that come with Alzheimer’s disease, the most common cause of dementia. Think of it as a clue, like smoke that hints at a fire somewhere. It is not a diagnosis on its own.
What did the study measure besides memory?
The team used a framework called intrinsic capacity, which is a fancy name for how well you function overall. They checked four things:
- Thinking: a short memory and attention test.
- Movement: a set of balance, walking and chair-stand tests.
- Mood: a questionnaire about feeling down.
- Nutrition: a questionnaire about eating well and staying nourished.
Each score was put on a 0 to 100 scale, then the four were averaged into one number.
What they found
The researchers split people into three equal groups based on their p-tau217 level, from lowest to highest. The middle score on the combined function measure went down step by step across the groups: 95.0, 93.5 and 90.5. The pattern held up after the researchers accounted for age, sex, body weight, education and the number of other health conditions.
The link was not only about thinking. People with higher p-tau217 also tended to score lower on mood, on nutrition and on walking speed. All of these links were statistically meaningful.
The team also looked at it from the other side. For every 10-point drop in the combined function score, the odds of being in the middle or highest p-tau217 groups, compared with the lowest, were higher. In plain words, lower overall function went with a greater chance of having a higher level of the marker.
The link also stayed in place when the researchers separately accounted for other brain-related blood markers, including GFAP, NfL, BACE1 and the ratio of two amyloid proteins. That suggests p-tau217 is not just echoing those other signals.
The authors conclude that the relationship goes beyond cognition alone. They say that longer studies following people over time are needed to learn what it means for your health in the years ahead.
What you can do today
This study does not change any advice. It does not show that the marker causes lower function, or that a high level predicts what will happen to you. What it does offer is a useful way of looking at your health: thinking, moving, mood and eating all matter together. Take two minutes today to jot down how you are doing in each of those four areas. Keep the note for your next routine checkup, so you and your doctor can see changes over time.
For clinicians and researchers
Design: Cross-sectional analysis of 200 community-dwelling adults aged ≥60 years (mean age 71.9 years, 74.0% women). Intrinsic capacity composite (MoCA, SPPB, PHQ-9, MNA-SF, rescaled to 0-100) was compared with plasma p-tau217 (Olink Target 48); linear regression adjusted for age, sex, BMI, education, multimorbidity.
Main result: Standardised composite IC was inversely associated with ln(p-tau217) (p = 0.001). Each 10-point lower IC was associated with higher adjusted odds of being in the T2/T3 versus T1 p-tau217 tertiles (p = 0.019).
Main limitation: Cross-sectional design precludes any inference on temporality or direction of the association; no clinical outcomes were assessed.
Open question: Whether lower multidomain intrinsic capacity predicts or follows rising plasma p-tau217, and its clinical and prognostic significance, requires longitudinal studies.
Cite this article
Mongevity Desk. Dementia blood marker p-tau217 tracks with more than memory in older adults. Mongevity. Published November 20, 2026. Accessed November 22, 2026. https://mongevity.science/brain/2026/11/dementia-blood-marker-p-tau217-intrinsic-capacity/Mongevity Desk. Dementia blood marker p-tau217 tracks with more than memory in older adults [Internet]. Mongevity; 2026 Nov 20 cited 2026 Nov 22]. Available from: https://mongevity.science/brain/2026/11/dementia-blood-marker-p-tau217-intrinsic-capacity/Mongevity Desk. (2026, November 20). Dementia blood marker p-tau217 tracks with more than memory in older adults. Mongevity. https://mongevity.science/brain/2026/11/dementia-blood-marker-p-tau217-intrinsic-capacity/
<a href="https://mongevity.science/brain/2026/11/dementia-blood-marker-p-tau217-intrinsic-capacity/">Dementia blood marker p-tau217 tracks with more than memory in older adults</a>
Free to share or quote with credit and a link.
Questions and answers
- What is p-tau217?
- It is a protein measured in the blood that scientists see as a promising sign of the brain changes seen in Alzheimer's disease.
- Does this study show that p-tau217 lowers how well I function?
- No. It took one snapshot, so it shows a link only. It cannot say which comes first or whether one causes the other.
- What does intrinsic capacity mean?
- It is a combined score of how well you function overall. This study used thinking, movement, mood and nutrition.
- Who took part in the study?
- The study included 200 community-dwelling adults aged 60 and older, with an average age of 71.9 years. About 74% were women.





